2019
DOI: 10.1016/j.thromres.2019.02.029
|View full text |Cite
|
Sign up to set email alerts
|

Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
25
0

Year Published

2019
2019
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 28 publications
(27 citation statements)
references
References 26 publications
2
25
0
Order By: Relevance
“…The population of patients with UE‐DVT in this study is similar to previous studies of UE‐DVT 12,13 with 13.8% having concurrent evidence of PE. In this study UE‐DVT was strongly associated with CVCs and malignancy with half of patients having catheter‐associated UE‐DVT, and 60% having a concurrent malignancy diagnosis.…”
Section: Discussionsupporting
confidence: 84%
See 3 more Smart Citations
“…The population of patients with UE‐DVT in this study is similar to previous studies of UE‐DVT 12,13 with 13.8% having concurrent evidence of PE. In this study UE‐DVT was strongly associated with CVCs and malignancy with half of patients having catheter‐associated UE‐DVT, and 60% having a concurrent malignancy diagnosis.…”
Section: Discussionsupporting
confidence: 84%
“…In this study UE‐DVT was strongly associated with CVCs and malignancy with half of patients having catheter‐associated UE‐DVT, and 60% having a concurrent malignancy diagnosis. Data from the RIETE Registry 12 of 2272 patients with UE‐DVT did not report any patients treated with DOACs while the COMMAND VTE 13 Registry reported 74 patients with UE‐DVT, four of whom were treated with DOACs.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Patients usually have signs and symptoms similar to primary UEDVT, but can also report reduced mobility, signs of PE, or no symptoms at all [ 15 ]. The most important risk factors are malignancy (prevalence 22–64%) and indwelling lines (prevalence 10–93%) [ 5 , 15 , 16 , 17 , 18 ]. Additional risk factors are recent surgery or trauma, the use of hormone therapy, and hereditary or acquired thrombophilia [ 5 , 17 , 19 ].…”
Section: Epidemiologymentioning
confidence: 99%